"
Team:Wageningen UR/ModifyingtheHepatitisB
From 2012.igem.org
(→The VLP) |
(→Hepatitis B and the Hepatitis B core Antigen VLP) |
||
| Line 7: | Line 7: | ||
The hepatitis B virus is a widespread virus causing liver infection. About 1% of the population in Western-Europe and Northern America is infected, and up to 5% in less developed countries (http://www.who.int/mediacentre/factsheets/fs204/en/). The virus can be spread by blood-to-blood contact or as std. This is the reason why we do not use full viruses, but the empty shells only. This prevents the transmission. | The hepatitis B virus is a widespread virus causing liver infection. About 1% of the population in Western-Europe and Northern America is infected, and up to 5% in less developed countries (http://www.who.int/mediacentre/factsheets/fs204/en/). The virus can be spread by blood-to-blood contact or as std. This is the reason why we do not use full viruses, but the empty shells only. This prevents the transmission. | ||
| - | [[File:HepBMap.png|500px|center|thumb|<p align="justify">''fig. 1 Map of the prevelance of Hepatitis B</p>]] | + | [[File:HepBMap.png|500px|center|thumb|<p align="justify">''fig.1 Map of the prevelance of Hepatitis B</p>]] |
== The VLP == | == The VLP == | ||
| Line 15: | Line 15: | ||
The inside of the VLP can be modified in a similar way, allowing controlled packaging of proteins inside the VLP. | The inside of the VLP can be modified in a similar way, allowing controlled packaging of proteins inside the VLP. | ||
| - | [[File:HepBwtVLP.jpg|500px|center|thumb|<p align="justify">''fig. 2 The full VLP of Hepatitis B from the Viper Database</p>]] | + | [[File:HepBwtVLP.jpg|500px|center|thumb|<p align="justify">''fig.2 The full VLP of Hepatitis B from the Viper Database</p>]] |
Revision as of 11:53, 19 September 2012
Hepatitis B and the Hepatitis B core Antigen VLP
Introduction
The hepatitis B virus is a widespread virus causing liver infection. About 1% of the population in Western-Europe and Northern America is infected, and up to 5% in less developed countries (http://www.who.int/mediacentre/factsheets/fs204/en/). The virus can be spread by blood-to-blood contact or as std. This is the reason why we do not use full viruses, but the empty shells only. This prevents the transmission.
fig.1 Map of the prevelance of Hepatitis B
The VLP
The empty shell, or Virus-Like Particle, is formed by the Hepatitis B core Antigen (HepBcAg). The VLP has already been used for the vaccination against Hepatitis B itself, back in 1980 (http://www.sciencedirect.com/science/article/pii/S0034528811004437, Virus-like particles: potential veterinary vaccine immunogens ) Afterwards, the Hepatitis B VLP has been modified and suggested to be used as carrier for epitopes of other pathogens. In this project, we will try to make the attachments of epitopes or ligands even more convenient. The external loop of the Hepatitis B core antigen can be modified, attaching the k-coil to the VLP. Using the PnA System, a wide variety of antigens and ligands can be attached. The inside of the VLP can be modified in a similar way, allowing controlled packaging of proteins inside the VLP.
fig.2 The full VLP of Hepatitis B from the Viper Database
